Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Eleven-Year Follow-up of Idiotype Vaccine and DA-EPOCH-Rituximab in Untreated Mantle Cell Lymphoma: Correlation of Survival with Idiotype Immune Response

Cliona Grant, MD, Sattva S. Neelapu, MD, Larry W Kwak, MD, PhD, Kieron Dunleavy, MD, Therese White, RN, Barry W. Miller, MS, Elaine S. Jaffe, MD, Seth M. Steinberg, PhD, Brian Healey Bird, MB, MRCP, Wyndham H. Wilson, MD, PhD

Blood (2011) 118 (21): 2707.

https://doi.org/10.1182/blood.V118.21.2707.2707

Published: 2011

Journal Articles

High Incidence of Autoimmune Complications during Combined Fludarabine and Rituximab Therapy in CLL: Rapid Clearance of Rituximab as a Contributing Factor

Ndegwa Njuguna, MD, Paul V Beum, PhD, Berengere Vire, PhD, Gerald E Marti, MD, PhD, Therese White, RN, Wyndham H. Wilson, MD, PhD, Ronald P Taylor, PhD, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 4208.

https://doi.org/10.1182/blood.V112.11.4208.4208

Published: 2008

Journal Articles

The Role of the Microenvironment for CLL Proliferation and Survival: Gene Expression Profiling of Leukemic Cells Derived from Blood, Bone Marrow and Lymph Nodes Reveals the B-Cell Receptor and NF κB as Dominant Signaling Pathways

Yair Herishanu, MD, Berengere Vire, PhD, Delong Liu, PhD, Federica Gibellini, PhD, Gerald E Marti, MD, PhD, Therese White, RN, Ndegwa Njuguna, MD, Nalini Raghavachari, PhD, Poching Liu, PhD, Stefania Pittaluga, MD, PhD, Peter J Munson, PhD, Wyndham H. Wilson, MD, PhD, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 356.

https://doi.org/10.1182/blood.V112.11.356.356

Published: 2008

Journal Articles

Molecular Effects of Rituximab on CLL Cells In Vivo : Rapid Increase in Serum Interferon gamma, Induction of a Distinct Tumor Cell Gene Expression Signature and Loss of CD20 Expression.

Adrian Wiestner, MD, PhD, Elinor Lee, BA, Berengere Vire, PhD, Federica Gibellini, PhD, Ndegwa Njuguna, MD, Yair Herishanu, MD, Delong Liu, PhD, Peter Munson, PhD, Nalini Raghavachari, PhD, Therese White, RN, Gerald E. Marti, MD, PhD, Wyndham H. Wilson, MD, PhD

Blood (2007) 110 (11): 2048.

https://doi.org/10.1182/blood.V110.11.2048.2048

Published: 2007

Journal Articles

ZAP-70 Expression Is Associated with Increased Migration to SDF-1 in Chronic Lymphocytic Leukemia.

Yuji Miura, MD, PhD, Elinor Lee, BA, Federica Gibellini, PhD, Therese White, RN, Gerald Marti, MD, Wyndham Wilson, MD/PhD, Adrian Wiestner, MD/PhD

Blood (2006) 108 (11): 587.

https://doi.org/10.1182/blood.V108.11.587.587

Published: 2006

Journal Articles

Rituximab Induces an Interferon Gene Expression Signature in Patients with CLL.

Elinor Lee, BA, Xiuli Xu, PhD, Peter Munson, PhD, Ronald Cooper, BA, Nalini Raghavachari, PhD, Therese White, RN, Gerald E. Marti, MD,PhD, Wyndham H. Wilson, MD,PhD, Adrian Wiestner, MD,PhD

Blood (2006) 108 (11): 4988.

https://doi.org/10.1182/blood.V108.11.4988.4988

Published: 2006

Journal Articles

Bortezomib Induces an Antioxidant and ER-Stress Response Gene Expression Signature in Mantle Cell Lymphoma: Implications for Response Prediction and Optimized Chemotherapy Regimens.

Edgar G. Rizzatti, MD, PhD, Helena Mora-Jensen, BS, Raymond Lai, MD/PhD, Masanori Daibata, MD, Therese White, RN, Kieron Dunleavy, MD, Wyndham Wilson, MD/PhD, Adrian Wiestner, MD/PhD

Blood (2006) 108 (11): 830.

https://doi.org/10.1182/blood.V108.11.830.830

Published: 2006

Journal Articles

Potent Single Agent Activity and Tumor Selectivity of Bortezomib in Mantle Cell Lymphoma: First Impressions from a Randomized Phase II Study of EPOCH-Rituximab-Bortezomib in Untreated Mantle Cell Lymphoma.

Adrian Wiestner, MD, PhD, Kieron Dunleavy, MD, Edgar G. Rizzatti, MD/PhD, Hui Liu, Msc, Gerald E. Marti, MD, Therese White, RN, Wyndham Wilson, MD/PhD

Blood (2005) 106 (11): 4744.

https://doi.org/10.1182/blood.V106.11.4744.4744

Published: 2005

Journal Articles

Differential Gene Expression in CLL Cells from Bone Marrow and Peripheral Blood Suggests a Role of Bone Marrow Stroma in Leukemic Cell Proliferation.

Adrian Wiestner, MD, PhD, Gerald E. Marti, MD, Eric M. Billings, PhD, Hui Liu, Msc, Elinor Lee, BA, Therese White, RN, Wyndham H. Wilson, MD/PhD

Blood (2005) 106 (11): 708.

https://doi.org/10.1182/blood.V106.11.708.708

Published: 2005

NARROW

Eleven-Year Follow-up of Idiotype Vaccine and DA-EPOCH-Rituximab in Untreated Mantle Cell Lymphoma: Correlation of Survival with Idiotype Immune Response

High Incidence of Autoimmune Complications during Combined Fludarabine and Rituximab Therapy in CLL: Rapid Clearance of Rituximab as a Contributing Factor

The Role of the Microenvironment for CLL Proliferation and Survival: Gene Expression Profiling of Leukemic Cells Derived from Blood, Bone Marrow and Lymph Nodes Reveals the B-Cell Receptor and NF κB as Dominant Signaling Pathways

Molecular Effects of Rituximab on CLL Cells In Vivo : Rapid Increase in Serum Interferon gamma, Induction of a Distinct Tumor Cell Gene Expression Signature and Loss of CD20 Expression.

ZAP-70 Expression Is Associated with Increased Migration to SDF-1 in Chronic Lymphocytic Leukemia.

Rituximab Induces an Interferon Gene Expression Signature in Patients with CLL.

Bortezomib Induces an Antioxidant and ER-Stress Response Gene Expression Signature in Mantle Cell Lymphoma: Implications for Response Prediction and Optimized Chemotherapy Regimens.

Potent Single Agent Activity and Tumor Selectivity of Bortezomib in Mantle Cell Lymphoma: First Impressions from a Randomized Phase II Study of EPOCH-Rituximab-Bortezomib in Untreated Mantle Cell Lymphoma.

Differential Gene Expression in CLL Cells from Bone Marrow and Peripheral Blood Suggests a Role of Bone Marrow Stroma in Leukemic Cell Proliferation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only